Evidence map›Paper›PMID 26945213›Full record

ArticleAmerican journal of physical medicine & rehabilitation2016

Biglycan Inhibits Capsaicin-Induced Substance P Release by Cultured Dorsal Root Ganglion Neurons.

Peng Shi, Er-Yun Chen, Gabriella Cs-Szabo, Ana Chee, Chadi Tannoury, Ling Qin, Han Lin, Steven An, Howard S An, Yejia Zhang

Abstract read
In one paragraph

Article in American journal of physical medicine & rehabilitation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Peng ShiFrom the Departments of Orthopedic Surgery (PS, AC, SA, HSA), Neurological Sciences (E-YC), and Biochemistry (GC-S), Rush University Medical Center, Chicago, Illinois; Department of Orthopedic Surgery, Boston University Medical Center, Boston, Massachusetts (CT); School of Biomedical Engineering, Science & Health Systems, Drexel University, Philadelphia, Pennsylvania (HL); Departments of Physical Medicine and Rehabilitation (YZ) and Orthopedic Surgery (LQ, YZ), Perelman School of Medicine, University of Pennsylvania; and Translational Musculoskeletal Research Center (TMRC), Philadelphia Veterans Affairs Medical Center (YZ), Philadelphia, Pennsylvania.
Er-Yun Chen
Gabriella Cs-Szabo
Ana Chee
Chadi Tannoury
Ling Qin
Han Lin
Steven An
Howard S An
Yejia Zhang
Boston Medical Center · US

Funding

Cell Therapy for the degenerating intervertebral discsK08HD049598 · NICHD · THOMAS JEFFERSON UNIVERSITY · PI ZHANG, YEJIA · 2007 to 2010
$566k
Cell Therapy for the Degenerating Intervertebral DiscI21RX001896 · VA · PHILADELPHIA VA MEDICAL CENTER · PI ZHANG, YEJIA · 2016 to 2017
–
Intramural VA VA999999NICHD NIH HHS K08 HD049598RRD VA I21 RX001896
6 · The paper itself

Abstract

objectiveThe purpose of this study was to examine the inhibitory effects of biglycan on substance P release from cultured sensory neurons in response to capsaicin. STUDY

designIn vitro study of cultured primary sensory neurons from the rabbit dorsal root ganglion (DRG). We interrogated the culture system function with capsaicin. Biglycan is an important structural component of the intervertebral disc that may regulate growth factors and inflammatory mediators. We tested the hypothesis that biglycan inhibits substance P release in response to capsaicin.

resultsThe DRG cultures were shown to contain both neurons and astrocytes by immunostaining using antibodies recognizing neuron and glial cell markers. Cultured DRG cells respond to capsaicin in a dose- and time-dependent manner (capsaicin dose ranges from 5 to 500 μmol/L; stimulation time ranges from 0 to 60 minutes). The neurons preincubated with biglycan released 27% less substance P compared with neurons without biglycan (n = 4, P = 0.036).

conclusionWe have established a DRG cell culture system, which contains both sensory neurons and the supporting astrocytes. Biglycan, an inhibitor of substance P release by DRG cultures, may serve as an ingredient in intradiscal injectables to reduce back pain.

Indexed as

AnimalsAstrocytesBiglycanCapsaicinCells, CulturedDose-Response Relationship, DrugGanglia, SpinalNeuronsRabbitsSensory System AgentsSubstance PBiglycanCapsaicinSensory System AgentsSubstance P

Identifiers

PMID26945213
PMCPMC4990466
OpenAlexW2290167788

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.